Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug;12(8):581-94.
doi: 10.1038/nrd4051. Epub 2013 Jul 19.

Validating therapeutic targets through human genetics

Affiliations
Review

Validating therapeutic targets through human genetics

Robert M Plenge et al. Nat Rev Drug Discov. 2013 Aug.

Abstract

More than 90% of the compounds that enter clinical trials fail to demonstrate sufficient safety and efficacy to gain regulatory approval. Most of this failure is due to the limited predictive value of preclinical models of disease, and our continued ignorance regarding the consequences of perturbing specific targets over long periods of time in humans. 'Experiments of nature' - naturally occurring mutations in humans that affect the activity of a particular protein target or targets - can be used to estimate the probable efficacy and toxicity of a drug targeting such proteins, as well as to establish causal rather than reactive relationships between targets and outcomes. Here, we describe the concept of dose-response curves derived from experiments of nature, with an emphasis on human genetics as a valuable tool to prioritize molecular targets in drug development. We discuss empirical examples of drug-gene pairs that support the role of human genetics in testing therapeutic hypotheses at the stage of target validation, provide objective criteria to prioritize genetic findings for future drug discovery efforts and highlight the limitations of a target validation approach that is anchored in human genetics.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cyst Fibros. 2011 Mar;10(2):71-85 - PubMed
    1. Br J Clin Pharmacol. 2011 Mar;71(3):403-10 - PubMed
    1. Nat Genet. 2008 Feb;40(2):189-97 - PubMed
    1. Nat Rev Genet. 2010 Jun;11(6):415-25 - PubMed
    1. Neuron. 2006 Dec 7;52(5):767-74 - PubMed

MeSH terms

LinkOut - more resources

-